A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
Clinical trial NCT00936546 · COMPLETED
Trial details
- NCT number
- NCT00936546
- Sponsor
- University Hospital, Ghent
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2015-06-03
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.